Monday, June 1, 2020

Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients

Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...

from NDTV News - Latest https://ift.tt/36PjXS6
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

America Faces Highest Inflation In Years As Prices Rise Across The Country

Consumer Price Index data released by the Bureau of Labor Statistics (BLS) showed that inflation reached 3.8 percent. from NDTV News Searc...